主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
GOSS
#3275
Gossamer Bio, Inc. Common Stock
0.4
2
+7.69%
版块:
基础:
利润货币:
日范围
年范围
日变化
+7.69%
每月变动
-84.33%
6个月变化
-83.00%
年变化
-63.16%
前一天收盘价
0.3
9
Open
0.4
2
Bid
Ask
Low
0.4
2
High
0.4
3
交易量
101
市场
股票
医疗保健
GOSS
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
75.53 M
76.48 M
94.98 M
225.58 M
227.22 M
—
Valuation ratios
Enterprise value
244.3 M
681.55 M
81.8 M
186.71 M
159.47 M
1.23 B
Price to earnings ratio
—
-3.61
-0.75
-0.82
-3.62
-14.5
Price to sales ratio
—
—
—
203.92
1.78
24.25
Price to cash flow ratio
—
-4.48
-0.92
-0.93
-59.01
-37.89
Price to book ratio
—
6.97
14.29
2.36
6.94
11.65
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.45
0.68
0.84
0.58
0.18
0.63
Return on equity %
0.76
1.93
18.99
2.86
1.92
8.4
Return on invested capital %
3 387.39
2 497.3
2 002.56
2 122.48
844.13
—
Gross margin %
100
—
—
100
100
400
Operating margin %
91.39 K
—
—
25.31 K
52.24
353.57
EBITDA margin %
—
—
—
—
—
—
Net margin %
95.06 K
—
—
24.77 K
49.28
1 418.51
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
13.51
8.32
5.32
5.94
6.88
20.28
Inventory turnover
—
—
—
—
—
—
Asset turnover
0
0
0
0
0.37
0.16
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0.05
0.08
0.04
0
0
—
Long term debt to total equity ratio
0.09
0.24
0.99
0.01
0
—
Per share metrics
Operating cash flow per share
—
2.52
2.21
1.04
0.02
0.41
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
—
4.35
3.02
1.94
1.3
6.75
Net current asset value per share
—
4.43
3.1
2.01
1.37
4.52
Tangible book value per share
—
1.62
0.14
0.41
0.13
0.72
Working capital per share
—
3.9
2.51
1.67
1.17
3.6
Book value per share
—
1.62
0.14
0.41
0.13
0.72
新闻
Intellia Therapeutics, Inc. (NTLA) Reports Q4 Loss, Tops Revenue Estimates
Is the SPDR S&P Biotech ETF (XBI) a ‘Strong Buy’ Right Now? - TipRanks.com
Arvinas, Inc. (ARVN) Reports Q4 Loss, Misses Revenue Estimates
Wedbush因试验结果下调Gossamer Bio股票评级
Gossamer Bio stock downgraded by Wedbush on trial results
Barclays因试验结果下调Gossamer Bio股票评级
Barclays cuts Gossamer Bio stock rating on trial results
Leerink因试验失败下调Gossamer Bio股票评级
Leerink cuts Gossamer Bio stock rating on trial miss
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.66%
美国股市收低;截至收盘道琼斯工业平均指数下跌1.66%
Tesla, Oracle among market cap stock movers on Monday